Navigation path

Pharmaceuticals - Community Register

  

Community list of not active medicinal products for human use


WITHDRAWN  

Product information

Invented name: Rivastigmine 3M Health Care Ltd.

   This product is authorized under a different brandname in the EU in the folowing languages:
   - Rivastigmina 3M Health Care Ltd. (PT)
Auth. number : EU/1/14/911
INN : rivastigmine
ATC: Anatomical main group: N - Nervous system
Therapeutic subgroup: N06 - Psychoanaleptics
Pharmacological subgroup: N06D - Anti-dementia drugs
Chemical subgroup: N06DA - Anticholinesterases
Chemical substance: N06DA03 - Rivastigmine
(See WHO ATC Index)
Indication: Symptomatic treatment of mild to moderately severe Alzheimer’s dementia.
Marketing Authorisation Holder: 3M Health Care Limited
1 Morley Street, Loughborough, Leicestershire, LE11 1EP United Kingdom

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/04/2014 Centralised - Authorisation EMEA/H/C/3824 (2014)2342 of 03/04/2014
21/08/2014 Centralised - Withdrawal (2014)6040 of 19/08/2014